The application of the diabetes prevention trial-type 1 risk score for identifying a preclinical state of type 1 diabetes (Q36047238)

11 August 2017

The application of the diabetes prevention trial-type 1 risk score for identifying a preclinical state of type 1 diabetes (English)

1 reference

11 August 2017

0 references

4

Jeffrey P Krischer

1 reference

11 August 2017

7

Carla J Greenbaum

1 reference

11 August 2017

2

Jay S Skyler

1 reference

11 August 2017

1

Jay M Sosenko

1 reference

Type 1 Diabetes TrialNet Study Group

11 August 2017

12

object named as

Type 1 Diabetes TrialNet Study Group

1 reference

11 August 2017

11

Jerry P Palmer

1 reference

11 August 2017

8

Lisa E Rafkin

1 reference

11 August 2017

Jeffrey Mahon

3

1 reference

11 August 2017

Craig A Beam

5

1 reference

11 August 2017

David C Boulware

6

1 reference

11 August 2017

Catherine Cowie

9

1 reference

11 August 2017

David Cuthbertson

10

1 reference

11 August 2017

Diabetes Prevention Trial-Type 1 Study Group

13

1 reference

11 August 2017

language of work or name

English

0 references

publication date

30 April 2012

1 reference

11 August 2017

1 reference

11 August 2017

35

1 reference

11 August 2017

7

1 reference

11 August 2017

1552-1555

1 reference

Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported

11 August 2017

start time

28 August 2021

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Co-stimulation modulation with abatacept in patients with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3379597

Validation of the Diabetes Prevention Trial-Type 1 Risk Score in the TrialNet Natural History Study

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3379597

Diagnosis and classification of diabetes mellitus

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3379597

Prognostic performance of metabolic indexes in predicting onset of type 1 diabetes

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3379597

Trends of earlier and later responses of C-peptide to oral glucose challenges with progression to type 1 diabetes in diabetes prevention trial-type 1 participants

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3379597

Pancreatic islet autoantibodies as predictors of type 1 diabetes in the Diabetes Prevention Trial-Type 1.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3379597

Pre-type 1 diabetes dysmetabolism: maximal sensitivity achieved with both oral and intravenous glucose tolerance testing

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3379597

Anti-CD3 monoclonal antibody in new-onset type 1 diabetes mellitus

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3379597

Antibodies to a 64,000 Mr human islet cell antigen precede the clinical onset of insulin-dependent diabetes

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3379597

Evidence for a long prediabetic period in type I (insulin-dependent) diabetes mellitus

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3379597

A risk score for type 1 diabetes derived from autoantibody-positive participants in the diabetes prevention trial-type 1.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3379597

Increasing the accuracy of oral glucose tolerance testing and extending its application to individuals with normal glucose tolerance for the prediction of type 1 diabetes: the Diabetes Prevention Trial-Type 1.

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3379597

Models for predicting type 1 diabetes in siblings of affected children

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3379597

Patterns of metabolic progression to type 1 diabetes in the Diabetes Prevention Trial-Type 1.

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3379597

Effects of oral insulin in relatives of patients with type 1 diabetes: The Diabetes Prevention Trial--Type 1.

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3379597

Beta-cell function and the development of diabetes-related complications in the diabetes control and complications trial

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3379597

Effects of insulin in relatives of patients with type 1 diabetes mellitus

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3379597

Rituximab, B-Lymphocyte Depletion, and Preservation of Beta-Cell Function

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3379597

Insulin Antibodies in Insulin-Dependent Diabetics Before Insulin Treatment

5 December 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22547092

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Effect of intensive therapy on residual beta-cell function in patients with type 1 diabetes in the diabetes control and complications trial. A randomized, controlled trial. The Diabetes Control and Complications Trial Research Group

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22547092

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.2337/DC12-0011

1 reference

11 August 2017

1 reference

11 August 2017

1 reference